"Il NSI, attivo dal 1° luglio 2009, permette di rispondere nel modo più appropriato, evitando inutili ridondanze, all’esigenza di sinergia fra le diverse specialità mediche nell'ambito delle Neuroscienze cliniche, offrendo ai pazienti un approccio alla malattia e un trattamento delle patologie all'avanguardia e sicuri, che considerano il percorso diagnostico-terapeutico e riabilitativo del paziente dalle prime ore della malattia fino al rientro a domicilio. All'interno del Neurocentro sono presenti Neurologia, Neurochirurgia, Neuroradiologia, Centro per la terapia del dolore e Neuroanestesia, Neuropsicologia e Neuroscienze."

During the past decade, Centro del Dolore, Neurocentro, Opedale Regionale di Lugano conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro del Dolore, Neurocentro, Opedale Regionale di Lugano" #1 collaborator was "Paolo Maino MD PhD, Sponsor Investigator" with 1 trials as a collaborator and "VU University of Amsterdam" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro del Dolore, Neurocentro, Opedale Regionale di Lugano" are "Chronic Low-back Pain" (1 trials) and "Chronic Pain" (1 trials). Many other conditions were trialed in "Centro del Dolore, Neurocentro, Opedale Regionale di Lugano" in a lesser frequency.

Most popular intervention types in "Centro del Dolore, Neurocentro, Opedale Regionale di Lugano" are "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Implantable Neurostimulator System (Spectra WaveWriter™ Spinal Cord Stimulator System), (Boston Scientific Neuromodulation Corporation, Valencia, California (CA), USA)" (1 trials) and "Intrathecal pump refill:" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro del Dolore, Neurocentro, Opedale Regionale di Lugano" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro del Dolore, Neurocentro, Opedale Regionale di Lugano". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro del Dolore, Neurocentro, Opedale Regionale di Lugano, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro del Dolore, Neurocentro, Opedale Regionale di Lugano, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".